These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14199701)

  • 1. [DIURETIC THERAPY OF THE ASCITIC FORM OF LIVER CIRRHOSIS WITH ANGIOTENSIN II AND THE MECHANISM OF ITS ACTION].
    PAZOUREK M; KUECHEL O; HORKY K
    Sb Lek; 1964 Oct; 66():289-96. PubMed ID: 14199701
    [No Abstract]   [Full Text] [Related]  

  • 2. [EFFECT OF BLOCKADE OF THE PERIPHERAL ACTION OF ALDOSTERONE ON THE EFFECT OF ANGIOTENSIN IN LIVER CIRRHOSIS].
    HORKY K; KUECHEL O; PAZOUREK M
    Sb Lek; 1964 Dec; 66():345-9. PubMed ID: 14253802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES.
    GINSBERG DJ; SAAD A; GABUZDA GJ
    N Engl J Med; 1964 Dec; 271():1229-35. PubMed ID: 14234267
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON THE SUBJECT OF DIURESIS WITH METOPIRONE (SU-4885)].
    CEREDA UG; FRANZINI P
    Minerva Med; 1964 Jul; 55():2335-8. PubMed ID: 14181820
    [No Abstract]   [Full Text] [Related]  

  • 6. [SODIUM DIURESIS AFTER ANGIOTENSIN II. (HYPERTENSIN CIBA) IN LIVER CIRRHOSIS, ITS MECHANISM AND CLINICAL USE].
    PAZOUREK M; KUECHEL O; HORKY K
    Cas Lek Cesk; 1964 Oct; 103():1205-6. PubMed ID: 14226140
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AUTOPERFUSION OF ASCITIC FLUID AND DIURETIC TREATMENT IN PREPARATION FOR SURGERY IN CIRRHOTIC PATIENTS].
    LONGO T; FORTI D
    Minerva Med; 1964 Jun; 55():1887-96. PubMed ID: 14175023
    [No Abstract]   [Full Text] [Related]  

  • 10. [OUR EXPERIENCE IN THE TREATMENT OF ASCITIC CIRRHOSIS WITH DIURETICS].
    DUBRISAY J; SCHNEIDER JJ; BOIFFIN A; MAHOUDEAU D
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1263-9. PubMed ID: 14098210
    [No Abstract]   [Full Text] [Related]  

  • 11. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ASSOCIATION OF INTRAVENOUS ALBUMIN WITH DIURETICS IN SEVERE ASCITIC CIRRHOSIS].
    VESIN P; TRAVERSO H
    Schweiz Med Wochenschr; 1964 Feb; 94():293-6. PubMed ID: 14137229
    [No Abstract]   [Full Text] [Related]  

  • 13. [DIURETIC THERAPY OF DECOMPENSATED HEPATIC CIRRHOSIS].
    COMOLI G; GHIRINGHELLI L; MADULI S
    Minerva Med; 1963 Sep; 54():2756-65. PubMed ID: 14094517
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone diuresis in patients with cirrhosis and ascites.
    Eggert RC
    Br Med J; 1970 Nov; 4(5732):401-3. PubMed ID: 5481518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone in diuretic regimens with meralluride or thiazides for pseudointractable ascites of cirrhosis.
    Gold H; Golfinos AJ; Mehta D; Messeloff CR; Zahm W
    J Clin Pharmacol New Drugs; 1972 Jan; 12(1):35-9. PubMed ID: 4480885
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of ascites in cirrhosis of the liver. II. Aldosterone antagonists.
    RIVERA A; VELASCO F; SUAREZ MA; DIES F
    Clin Pharmacol Ther; 1963; 4():154-61. PubMed ID: 13974133
    [No Abstract]   [Full Text] [Related]  

  • 19. [INDICATIONS FOR THE TREATMENT OF ASCITIC CIRRHOSIS ACCORDING TO ITS CLINICAL FORMS].
    DUPUY R; VALLIN J; BOUTELLIER D; LODS JC
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1271-5. PubMed ID: 14100799
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.